We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...
Research suggests that omega-3s can support brain health, especially for people who carry a gene that raises the risk of ...
A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...